News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Daily News EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management L.A. McKeown September 22, 2021
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017
News Daily News Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns Shelley Wood September 13, 2016
News Daily News Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways Michael O'Riordan May 02, 2016
News Conference News TCT 2015 Low 1-Year Event Rates Seen After TAVR With Sapien 3 Todd Neale October 15, 2015
News Conference News EuroPCR 2014 New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke L.A. McKeown May 23, 2014
News Conference News ESC 2013 New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups Caitlin E. Cox September 03, 2013